Accessibility statement

Drug discovery using crystals

Tony Wilkinson

The ligand binding domain of the oestrogen receptor with bound oestradiol (spheres) and target peptide (magenta). Courtesy Rod Hubbard (Protein Data Bank Entry 2j7x)
  • 26 September 2014
    5pm - 9pm

  • York Medical Society (map)

  • FREE admission
    No booking required

  • Wheelchair accessible
    (through the garden)

Event details

Drugs work by interacting with targets in the body. These targets are usually proteins which are large molecules containing thousands of atoms. Drugs bind tightly and selectively to their targets so that they can be effective with minimal side effects. X-Ray analysis of protein crystals shows their structure and allows us to design drugs to selectively and effectively bind to them.

Here we will exhibit protein crystals and illustrate using examples of work carried out in York, how protein structures have led to the development of improved drugs. So discover one of the exciting processes used in modern drug design!